Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02341235 · ClinicalTrials.gov registry record · NA

Self-monitoring Activity: a Randomized Trial of Game-oriented Applications

A NA study, sponsored by The University of Texas Medical Branch, Galveston.

Completed
Registry status
NA
Development phase
90
Enrollment target

NCT02341235: Completed NA study, sponsored by The University of Texas Medical Branch, Galveston.

NCT02341235 is a NA study that has completed, run by The University of Texas Medical Branch, Galveston. The registered enrollment target is 90 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02341235, a NA study, has completed, sponsored by The University of Texas Medical Branch, Galveston.

COMPLETED
Registry status
NA
Development phase
90 participants
Enrollment target

Study Summary

The purpose of this study is to compare an enhanced intervention that includes narrative and game components to a standard intervention that only targets self-monitoring. These approaches will be tested among postmenopausal breast cancer survivors who are sedentary and overweight.

Primary Outcome

Minutes of moderate-vigorous physical activity per day (averaged over a 7 day period) at baseline and 6 months.

Interventions

  • BEHAVIORAL Standard intervention
  • BEHAVIORAL Game intervention

Trial Details

FieldValue
Enrollment Target 90 participants
Start Date 2015-02
Est. Completion 2021-06-30
Phase NA

What the finished NCT02341235 record still lists

NCT02341235 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 90 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower).

The record links to 0 conditions, and to 2 interventions - of which Standard intervention is the first listed.

NCT02341235 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02341235 about?

NCT02341235 is a clinical study titled "Self-monitoring Activity: a Randomized Trial of Game-oriented Applications". The purpose of this study is to compare an enhanced intervention that includes narrative and game components to a standard intervention that only targets self-monitoring. These approaches will be tested among postmenopausal breast cancer survivors who are sedentary and overweight.

What is the current status of trial NCT02341235?

This trial is currently completed. It is a NA study. The enrollment target is 90 participants. The study started on 2015-02. Estimated completion is 2021-06-30.

What interventions are being tested in trial NCT02341235?

The interventions under investigation include: Standard intervention (BEHAVIORAL), Game intervention (BEHAVIORAL).

Who is sponsoring clinical trial NCT02341235?

This trial is sponsored by The University of Texas Medical Branch, Galveston, which has 203 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT02341235's enrollment target sits among peer trials

90 941st of 2000 higher than 1,029 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02521311 · 90 participants · Phase 2

    Assessment of Clemastine Fumarate as a Remyelinating Agent in Acute Optic Neuritis (ReCOVER)

  • NCT02939573 · 90 participants · Phase 2

    A Randomized Multicenter Study for Isolated Skin Vasculitis

  • NCT03128879 · 90 participants · Phase 2

    Venetoclax With Ibrutinib or Acalabrutinib in Pts. With High-risk CLL

  • NCT03184038 · 90 participants · NA

    Neurocognition in Patients With Multiple Brain Metastases Treated With Radiosurgery

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02341235, the US trial registry maintained by the National Library of Medicine. NCT02341235 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.